0001209191-23-047913.txt : 20230901
0001209191-23-047913.hdr.sgml : 20230901
20230901082011
ACCESSION NUMBER: 0001209191-23-047913
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230831
FILED AS OF DATE: 20230901
DATE AS OF CHANGE: 20230901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Su Zhen
CENTRAL INDEX KEY: 0001991642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 231230690
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SUITE 210
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-31
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001991642
Su Zhen
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVENUE
NEWTON
MA
02459
1
0
0
0
0
Nonstatutory Stock Option (right to buy)
1.28
2023-08-31
4
A
0
68000
0.00
A
2033-08-30
Common Stock
68000
68000
D
This option was granted on August 31, 2023. The shares underlying the option vest as to one-third (1/3) of the shares on August 31, 2024 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter.
/s/Nancy Smith as Attorney-in-Fact for Zhen Su
2023-09-01